GSK Revenue 2010-2022 | GSK

GSK annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • GSK revenue for the quarter ending September 30, 2022 was $9.221B, a 26.33% decline year-over-year.
  • GSK revenue for the twelve months ending September 30, 2022 was $43.897B, a 3.66% decline year-over-year.
  • GSK annual revenue for 2021 was $46.91B, a 7.14% increase from 2020.
  • GSK annual revenue for 2020 was $43.783B, a 1.58% increase from 2019.
  • GSK annual revenue for 2019 was $43.1B, a 4.77% increase from 2018.
GSK Annual Revenue
(Millions of US $)
2021 $46,910
2020 $43,783
2019 $43,100
2018 $41,140
2017 $38,904
2016 $37,798
2015 $36,578
2014 $37,916
2013 $41,475
2012 $41,896
2011 $43,940
2010 $43,903
2009 $44,421
GSK Quarterly Revenue
(Millions of US $)
2022-09-30 $9,221
2022-06-30 $8,699
2022-03-31 $13,123
2021-12-31 $12,853
2021-09-30 $12,516
2021-06-30 $11,311
2021-03-31 $10,229
2020-12-31 $11,509
2020-09-30 $11,169
2020-06-30 $9,461
2020-03-31 $11,644
2019-12-31 $11,509
2019-09-30 $11,573
2019-06-30 $10,040
2019-03-31 $9,978
2018-12-31 $6,661
2018-09-30 $10,544
2018-06-30 $9,949
2018-03-31 $13,986
2017-12-31 $10,128
2017-09-30 $10,268
2017-06-30 $9,361
2017-03-31 $9,147
2016-12-31 $9,429
2016-09-30 $9,905
2016-06-30 $9,373
2016-03-31 $8,925
2015-12-31 $9,617
2015-09-30 $9,498
2015-06-30 $9,020
2015-03-31 $8,512
2014-12-31 $9,319
2014-09-30 $9,120
2014-06-30 $9,472
2014-03-31 $9,440
2013-12-31 $11,235
2013-09-30 $10,518
2013-06-30 $10,166
2013-03-31 $9,875
2012-12-31 $10,782
2012-09-30 $10,512
2012-06-30 $10,210
2012-03-31 $10,717
2011-12-31 $10,990
2011-09-30 $11,304
2011-06-30 $10,950
2011-03-31 $10,544
2010-12-31 $11,636
2010-09-30 $10,560
2010-06-30 $9,196
2010-03-31 $11,286
2009-12-31 $13,218
2009-09-30 $11,097
2009-06-30 $10,527
2009-03-31 $9,734
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.890B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00